Fertility app targeting millennial women hits iOS devices

The Bump, a media company targeting millennial parents, announced the launch of Shine Period and Fertility Tracker app for iPhone. Read more ...

CDC: Flu vaccination rates on the rise

With influenza season approaching, health experts at a Nationa Foundation for Infectious Disease news conference reinforced the need for everyone six months of age and older to get vaccinated with updated 2015-2016 vaccine.  Read More ...

CDC to issue draft guideline on opioid prescribing

The Centers for Disease Control and Prevention this week announced that a new draft guideline for prescribing opioids to patients with chronic pain was in the works.  Read More ...

5 states still seeing obesity rates on the rise

U.S. adult obesity rates remained mostly steady ― but high ― this past year, increasing in Kansas, Minnesota, New Mexico, Ohio and Utah and remaining stable in the rest of the states. Read More ...

Current news

Fujisawa Bristol Corporation on Tuesday introduced Phluseptic Cold and Flu wipes, which offer protection against cold and flu germs, with 99.9% effectiveness when used as directed.
Ansell last week announced its 50th year designing and manufacturing Gammex surgical gloves.
GM Pharmaceuticals on Tuesday introduced DayClear Allergy and DayClear Sinus Relief, a product line that addresses those battling Celiac Disease, diabetes, alcohol intolerance, acetaminophen intolerance and dye sensitivities.
NBTY on Tuesday launched Ester-C Immune Charge Gummies to help busy families get 100% of the daily value of the patented Ester-C formula.
Along with VoicePort and Scientific Technologies Corp., the Pharmacy Quality Alliance will be rolling out the ImmuSMART project, which will use sate immunization registry data to identify patients with gaps in vaccinations for the flu, shingles and pneumonia.
The Pharmacy Technician Certification Board announced Monday that it had been named an official observer organization at the International Pharmacy Federation (FIP).
The FDA recently granted Merck’s Kaytruda (pembrolizumab) injection accelerated approval for use among patients with metastatic non-small cell lung cancer and who have tumors expressing the protein PD-L1.
This annual campaign focuses on raising awareness of breast cancer, the second leading cause of death in women today. What is your pharmacy planning to increase awareness in your community?
Understanding breast cancer is essential for everyone - after skin cancer, breast cancer is the second most common cancer among women worldwide.
Successful treatment requires a team of committed health professionals working toward the common goal for each patient: to become “cancer free” - there is also a significant role for the community pharmacist to provide long term oral therapy and supportive care.

CPE Monitor Reminders

As of May 1, 2014, ACPE-accredited CE Providers, such as Drug Store News, may no longer issue statements of credit. All credit awarded by ACPE-accredited providers to pharmacists and pharmacy technicians must be via CPE Monitor. Any statements obtained from the Drug Store News website are no longer valid statements of credit. You MUST obtain your statement of credit from CPE Monitor at MyCPEMonitor.net.

Please be sure that you enter your correct NABP e-PID number in your Drug Store News CE profile. This ensures your CE credit will be transmitted to CPE Monitor so you may receive credit for completed CPE activities. To look up your e-PID number go to the MyCPEMonitor.net or NABP.net site and search the system for their NABP e-PID number.